Stay updated with breaking news from Spherix Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The patient switch territory is evolving as more agents become available. Spherix's RealWorld Dynamix™ report allows for an inside look into...
/PRNewswire/ -- Since 2017, Spherix Global Insights has been monitoring the U.S. renal anemia market landscape, capturing nephrologists' perceptions and...
/PRNewswire/ -- Analysis from Spherix Global Insights quarterly market tracker, RealTime Dynamix™: Ulcerative Colitis, reveals that at twenty (20) months after...
/PRNewswire/ -- AbbVie's Humira (adalimumab) is the world's best selling drug, but the entry of biosimilar challengers, with Amgen's Amjevita being the first...
/PRNewswire/ -- With SGLT2 inhibitors increasingly becoming the standard of care for diabetic and non-diabetic CKD patients, the broader CKD treatment has...